Based on the information above, and doing a simple regression analysis, we are able to estimate that about 33 million people would be suffering from osteoarthritis by 2009. Let's say that our new product becomes a breakthrough, and we are able to capture 50% of the market. The other competing products, given their problems as mentioned in this project, are still able to overcome some of their difficulties and they now share the remaining 50% of  the market. With those assumptions, we would still be responsible in treating about 17 million people with our novel approach to cartilage regeneration. Assuming that a typical patient would need 30 cubic centimeters of the cartilage,  about 18000 cubic feet would be needed by 2009.

Hypothetically, a  typical laboratory manufacturing our product can meet the demand of  100 cubic feet of cartilage in a year. That leaves us with the need to establish 180 of such labs throughout the United States. With a staff including scientists and lab technicians of about 20 people working in a typical lab, our estimates lead us to conclude that 3600 new jobs for tissue engineers and lab technicians would become available.